Articles about merck

Report: Merck in ‘advanced talks’ to acquire Seattle-area biotech giant Seagen for around $40B

A new Wall Street Journal report revealed that Merck is in “advanced talks” to acquire Seattle-area biotech giant Seagen in… Read More

Gates Foundation commits up to $120M to support access to new COVID-19 pill

The Bill & Melinda Gates Foundation will provide up to $120 million to help lower-income countries access a new pill… Read More

Gates Foundation gives $122M for Univ. of Washington study on monthly HIV pill

Researchers at the University of Washington will test a once-a-month pill to prevent HIV in women with a new $122… Read More

Navigating Cancer’s founder and former CEO sues its investor Merck, alleging gender bias and interference with acquisition talks

The founder and former CEO of Seattle health tech startup Navigating Cancer, Gena Cook, is suing one of its investors,… Read More

Merck research chief Roger Perlmutter touts Seattle biotech strength after $300M Immune Design deal

Two months after Merck acquired Seattle-based biotech Immune Design for $300 million, the president of Merck Research Laboratories, Roger Perlmutter,… Read More

Drug giant Merck pays $300M to acquire Seattle biotech company Immune Design

Merck, one of the world’s largest drugmakers, agreed to buy Seattle-based biotechnology company Immune Design for $300 million in cash.… Read More

Immunotherapy dramatically increases survival rate of lung cancer patients, according to new study

Immunotherapies are quickly increasing survival rates for some of the deadliest cancers in the world. A new study on immunotherapy… Read More

Merck subsidiary StayWell acquires Portland digital health startup Provata Health

StayWell, a Pennsylvania-based subsidiary of pharmaceutical giant Merck, announced Monday that it has acquired Portland, Ore., based digital health company… Read More

Gates Foundation leads $14M funding round for Just Biotherapeutics to battle infectious diseases

Seattle-based Just Biotherapeutics said Monday it closed a $14 million funding round led by the Bill & Melinda Gates Foundation.… Read More

Biotechnology company NanoString partners with Merck to create test for anti-cancer drug

NanoString Technologies, a Seattle-based company that researches how genetic and immune markers can be used to predict patient response to… Read More